Please wait while we open this resource.

Privacy Policy Terms of Service

TUMOUR LYSIS SYNDROME — OslerMarket

Loading resource…

K

Ask Osler Library Learn

Browse by category

Guidelines & protocols Clinical notes Lecture slides SASI Bank Medicines & prescribing Clinical tools Clinical reviews

Featured collections

Clinical Guidelines & Protocols Structured Clinical Notes Lecture Slides & Teaching Decks SASI Past Papers Medicine Guides & Formularies Clinical Tools & Calculators Obstetrics & Gynaecology Paediatrics & Child Health Internal Medicine Surgery Exam Preparation Pack Cardiology Reference Library Emergency Medicine Pack

Your library

Saved Submissions

Clinical reviews

TUMOUR LYSIS SYNDROME

Scott C. Howard, Anna Avagyan, Biruh Workeneh, Ching-Hon Pui

PDF202417 pages2.4 MB

This document provides a comprehensive overview of tumour lysis syndrome, including its mechanisms, diagnosis, prevention, and management strategies. It highlights the importance of monitoring and hydration in preventing TLS, particularly in patients with a large cancer cell mass. The management options discussed include the use of rasburicase and allopurinol, along with considerations for specific patient populations at risk for complications.

Sign in to open

Ask this resource

Answers use this document only.

Your first question is free.

More like this

Resources from the same specialty and type. Curated links will replace these when added.

Clinical Resources

Documents that extend or complement this resource.

9

Exploring treatment options in cancer: tumor treatment strategies

Same clinical topic · Oncology

SGLT2 INHIBITORS AND RISK OF DISTANT METASTASIS IN PATIENTS WITH BREAST CANCER AND TYPE 2 DIABETES: A TARGET TRIAL EMULATION WITH BIOLOGICAL PLAUSIBILITY ANALYSIS

Same clinical topic · Oncology

PERIOPERATIVE CHEMOTHERAPY WITH FLUOROURACIL PLUS LEUCOVORIN, OXALIPLATIN, AND DOCETAXEL VERSUS FLUOROURACIL OR CAPECITABINE PLUS CISPLATIN AND EPIRUBICIN FOR LOCALLY ADVANCED, RESECTABLE GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA (FLOT4): A

Same clinical topic · Oncology

PERIOPERATIVE ATEZOLIZUMAB PLUS FLUOROURACIL, LEUCOVORIN, OXALIPLATIN, AND DOCETAXEL FOR RESECTABLE ESOPHAGOGASTRIC CANCER: INTERIM RESULTS FROM THE RANDOMIZED, MULTICENTER, PHASE II/III DANTE/IKF-S633 TRIAL

Same clinical topic · Oncology

NEOADJUVANT AND ADJUVANT PEMBROLIZUMAB PLUS CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC OR GASTRO OESOPHAGEAL CANCER (KEYNOTE-585): AN INTERIM ANALYSIS OF THE MULTICENTRE, DOUBLE-BLIND, RANDOMISED PHASE 3 STUDY

Same clinical topic · Oncology

HIV Associated Cancers and related diseases (2)

Same clinical topic · Oncology

UPDATE 2026: MANAGEMENT OF SMALL CELL LUNG CANCER

Same clinical topic · Oncology

HIV-Associated Cancers and Related Diseases

Same clinical topic · Oncology

HIV-Associated Cancers and Related Diseases

Same clinical topic · Oncology

Report a problem with this resource

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask Osler Library Learn

Home Ask Library Learn Account